Reactive oxygen species (ROS) including superoxide anions (O2-) play a key role in atherogenesis, and endothelial cells have the ability to generate ROS. To investigate the enzymatic sources of ROS and the effects of lysophosphatidylcholine (LPC), an atherogenic lipid, we measured ROS production in cultured bovine aortic endothelial cells (BAECs) by the lucigenin-enhanced chemiluminescence (CL) method and electron spin resonance (ESR). BAEC homogenates had the enzymatic activity of NADH/NADPH oxidase.
Introduction
Oxidative stress by reactive oxygen species (ROS) in the vessel wall plays a key role in the development of atherosclerosis.
Among the ROS, superoxide anions (O2-) are involved in atherogenesis by several mechanisms, including direct injury of the endothelium, oxidation of low density lipoprotein (LDL), inactivation of endothelium-derived relaxing factor (EDRF), and induction of the redox-sensitive gene such as vascular cell adhesion molecule (VCAM-1) and monocyte chemoattractant protein (MCP-1) (1, 2). Furthermore, O2-rapidly inactivates NO, and O2-and NO react with each other to generate peroxynitrite anion (ONOO-), which is considered to be one of the pathogens of atherosclerosis (3) . The generation of ROS increases under various pathological conditions such as hyperlipidemia (4), hypertension (5), diabetes mellitus (6), and heart failure (7), and may consequently contribute to endothelial dysfunction.
In the vessel wall, ROS are produced at several locations, including vascular smooth muscle cells (8, 9), endothelial cells (10, 11), and adventitial fibroblasts (12). The intracellular origins of ROS in endothelial cells and the regulatory mechanism of ROS production under pathological conditions are, however, poorly understood.
Oxidized low-density lipoprotein (LDL) has been proposed to be a crucial factor in atherogenesis.
Lyso-phosphatidylcholine (LPC), which accumulates in oxidized LDL (13), increases in atherosclerotic lesions (14) . Accumulating evidences indicate that LPC imparts various atherogenic properties to endothelial cells. For example, LPC inhibits endothelium-dependent vasorelaxation (15, 16), acts as a selective chemoattractant to mononuclear leukocytes (17), and induces expression of adhesion molecules such as intercellular adhesion molecules (ICAM-1), VCAM-1, P-selectin (18, 19) . LPC also activates nuclear factor-kB (NF-kB), a redox-sensitive transcriptional factor, in endothelial cells (20, 21) . Furthermore, LPC increases vascular O2-production in segments of the rabbit aorta (22) . Given the importance of oxidative stress, the investigation of the regulatory mechanisms of endothelial production of ROS by atherogenic lipids such as LPC might provide important insights into understanding the pathogenesis of atherosclerosis.
In the present study, we investigated the production capability and intracellular origins of ROS in cultured endothelial cells by lucigenin-enhanced chemiluminescence (CL) and electron spin resonance (ESR), and examined the effects of LPC on ROS production and its underlying signal transduction. production in BAECs (9.97+0.95 C.P.M./mg protein and 10.5+2.0 C.P.M./mg protein, respectively, n=4, P< 0.05 vs LPC), whereas PP-2, a specific inhibitor of the Src family of tyrosine kinase (31), had no effect.
Detection of ROS from BAECs by ESR-Spin Trapping
Since some investigators questioned the accuracy of lucigenin-enhanced CL for measurement of O2-because of autooxidation of lucigenin (32), ESR-spin trapping with DMPO was carried out to confirm the generation of ROS from BAECs. As shown in Figs. 4A and 4B, LPC in- NADH/NADPH oxidase system and tyrosine kinase inhibitors, but not by protein kinase C inhibitors. These observations indicate that LPC activates NADH/NADPH oxidase to enhance ROS production through the tyrosine kinase-mediated pathway in endothelial cells. In the experiments using cell homogenates of BAECs, NADH and NADPH stimulated O2-production, but xanthine did not. The NADH-dependent oxidase activity was higher than the NADPH-dependent one (Figs. 1A, 1B ). This enzymatic character resembles the NADH/NADPH oxidase activity in cultured vascular smooth muscle cells, but not that of phagocyte oxidase activity (8) . IDP inhibited NADPH-elicited O2-production but did not affect NADH-elicited O2-production.
In the experiments using intact BAECs cultured on microcarrier beads , IDP and DPI significantly reduced basal O2-production, whereas oxypurinol, rotenone, indomethacin, and ETYA had no effect, suggesting that xanthine oxidase, the mitochondrial electron transport, cyclooxygenase and lipoxygenase do not contribute to 2-generation.
These data suggest that at least two forms of ROS-generating enzymes might exist in endothelial cells : NADPH oxidase, an IDP-sensitive enzyme, probably containing flavoprotein , and NADH oxidase, an IDP-insensitive enzyme . In the enzymatic reaction, the NADH-dependent oxidase activity was higher than the NADPH-dependent one, however , NADPH-dependent oxidase mainly contributed to the 02-production from intact BAECs (Fig. 2A) . This finding suggests that NADPH-dependent oxidase is constitutively active in intact BAECs.
The NADH/NADPH oxidase system in endothelial cells might be identical to the phagocytic oxidase system . The components of phagocytic NADPH oxidase are expressed in human or rat endothelial cells (34, 35). The activity of O2--generating enzymes in BAECs was localized in the membrane fraction on cell fractionation , and calcium ionophore (A23187) and phorbor ester (TPA) activated these enzymes.
These characteristics are also similar to those of phagocytic oxidase . Some characteristics of endothelial oxidase observed in the present study, however, are not consistent with the phagocytic oxidase system. First, the endothelial oxidase system appears to be constitutively active and does not exhibit oxidative bursts. Second, in contrast to endothelial oxidase, NADH-dependent oxidase activity in phagocytes is extremely lower than NADPH-dependent activity (36) . It is plausible that one of the endothelial oxidases is an isoenzyme of phagocytic oxidase. The molecular identi- In the experiments with intact BAECs, LPC increased O2-production and NADPH oxidase inhibitors significantly reduced it to near the basal level (Fig.  3A) . This suggests that LPC-elicited endothelial 02-production is mainly due to NADPH oxidase.
The reliability of lucigenin as a probe for O2-measurement has been questioned because of its autooxidation (32), although there are conflicting reports in this regard (37). Therefore, the investigation by the ESR spin-trap- (eq. 1) (eq. 2) (eq. 3) Thus, the ESR study confirmed the importance of these oxidase systems in ROS generation induced by LPC in endothelial cells (Fig. 4C) . Pietersma et al. have demonstrated that the expression of VCAM-1 is dependent on cytochrome P450 monooxygenase in endothelial cells, mentioning that cytochrome P450 monooxygenase is a major ROS generating system (39), however, there was no data on the formation of ROS in their study. In the present study, two kinds of cytochrome P450 inhibitors had no effects on the formation of the DMPO-OH adduct signal induced by LPC. Although DPI had an inhibitory effect on cytochrome P450 monooxygenase, the involvement of this monooxygenase is unlikely. LPC enhanced O2-production in intact BAECs, whereas it did not increase in cell homogenates (data not shown). This suggests that LPC does not directly activate NADH/ NADPH oxidase,but that there are some specific signaling pathways to the activation of the oxidase.
The intracellular signal transduction evoked by LPC in endothelial cells is not well defined, although several studies have already been published.
LPC increases O2-production through PKC activation in the isolated rabbit aorta (22). In contrast, the upregulated expression of ICAM-1 by LPC in human endothelial cells depends on the tyrosine kinase pathway (20). Therefore, we examined the potential role of protein kinases in LPC-induced O2-production by using protein kinase inhibitors. In the present study, phorbor ester (TPA) stimulated O2-production at the basal level, whereas selective PKC inhibitors such as Ro31-8220 and GF109203X failed to inhibit LPC-induced O2-production in endothelial cells. The conventional PKC subfamily (PKCa, PKC/3), the novel PKC subfamily (PKCE), and the atypical PKC subfamily (PKC) are present in endothelial cells (40). Ro31-8220 and GF109203X belong to a series of bisindolylmaleimides that selectively inhibit the conventional PKC subfamily (PKCa, PKC/3, PKCy) (41, 42). Ro31-8220 also inhibits PKCE (41). Therefore, the activation of PKCa, PKC/3, PKCy and PKCE may not be involved in LPC-induced O2-production. LPC inhibits novel PKCo-and PKCE isolated from rat brain, and therefore such PKCs may not be related to LPC-induced O2-production (43). However, the involvement of PKC remains unknown. On the other hand, genistein and herbimycin A significantly inhibited LPC-induced O2-production in endothelial cells, whereas PP-2 had no effect. Since PP-2 is a specific inhibitor of the Src family of tyrosine kinases, our observations indicate that some tyrosine kinase other than the Src family was probably involved in the pathway of this effect of LPC. LPC-induced O2-production was partially but not completely inhibited by tyrosine kinase inhibitors. Nishioka et al. reported that LPC stimulates O2-generation in human neutrophils through PI3 kinase activation (44). However, the involvement of PI3 kinase on activation of endothelial NADH/NADPH oxidase was not examined in this study. Further investigation is necessary for identification of the pathway of the effect of LPC.
LPC contributes to the induction and progression of atherosclerosis by a variety of biological effects including inhibition of endothelium-dependent vasorelaxation (15, 16), chemoattractant to mononuclear leukocytes (17), and induction of adhesion molecules (18, 19). Our findings might, in large part, explain these atherogenic properties of LPC. First, O2-rapidly inactivates NO, and O2-and NO react with each other to generate ONOO-. LPC potently inhibits bradykinin-induced turnover of phosphoinositides as well as calcium transients, and sequentially the release of EDRF from endothelial cells (24). Taken together with the present study, not only the inhibitory action on the signal transduction for the release of EDRF, but also the enhancement of 02-production is probably responsible for suppression of endothelium-dependent vasorelaxation by LPC. Second, LPC induces expression of adhesion molecules such as ICAM-1 by activating the redox-sensitive transcriptional factor, NF-KB (20). As NF-KB is activated by ROS, LPC might activate NF-KB through O2-production to induce the expression of adhesion molecules. Third, O2-takes the principal part in oxidation of LDL. It is suggested that LPC formed during oxidation of LDL increases O2-production in the vessel wall, which may further promote LDL oxidation and accelerate the development of atherosclerosis.
Thus, the increase of oxidative stress by endothelial O2-production is very likely related to the atherogenic properties of LPC.
In summary, NADH/NADPH oxidase is a major source of the basal production of O2-in endothelial cells. LPC enhances O2-production through this system, and this effect of LPC is very likely mediated by the tyrosine kinase-dependent pathway. Our findings provide an insight into the molecular mechanisms of how atherogenic lipids influence the pathogenesis of vascular diseases.
